Sivu 1 alkaen 31 tuloksia
TECHNICAL FIELD
The present invention relates to a carboxylic acid compound. More particularly, the present invention relates to:
(1) a carboxylic acid compound represented by formula (I)
##STR00002## (in the formula, all symbols have the same meanings as those which will be mentioned later) and a
FIELD OF THE INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for neuro-protective purposes such as controlling chronic or acute neurotoxic injury or brain damage resulting from neuro-degenerative diseases. For
FIELD OF THE INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for neuro-protective purposes such as controlling chronic or acute neurotoxic injury or brain damage resulting from neuro-degenerative diseases. For
FIELD OF THE INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for neuro-protective purposes such as controlling chronic or acute neurotoxic injury or brain damage resulting from neuro-degenerative diseases. For
SUMMARY OF INVENTION
The present invention relates to novel therapeutically useful derivatives of the thiophene-2-carboxylic acid of the general formula ##STR2## in which R in position 3 or 4 is hydrogen, methyl, chlorine or bromine and R.sub.1 is hydrogen or C.sub.1 -C.sub.4 -alkyl, and the
BACKGROUND OF THE INVENTION
1. Field of the Invention The present invention relates to novel tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidine compounds that are antagonists of alpha V (.alpha.v) integrins, for example .alpha..sub.v.beta..sub.3 and .alpha..sub.v.beta..sub.5 integrins, their
FIELD OF THE INVENTION
The present invention relates to antithrombotic compounds 2-alkyl aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indole-3-carboxylic acid esters/amides, pharmaceutically acceptable salts and compositions thereof useful in treatment of intravascular thrombosis such as
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/CN2013/074739, filed on Apr. 25, 2013, published in Chinese, which claims priority from Chinese Patent Application No. 201210125154.4, filed Apr.
TECHNICAL FIELD
The present invention relates to (1) a carboxylic acid compound represented by formula (I)
##STR00002##
wherein all symbols have the same meanings as follows, salts thereof, solvates thereof, and prodrugs thereof, (2) a process for producing the same, (3) a pharmaceutical composition
TECHNICAL FIELD
The present invention relates to (1) a carboxylic acid compound represented by formula (I)
##STR00002##
wherein all symbols have the same meanings as follows, salts thereof, solvates thereof, and prodrugs thereof,
(2) a process for producing the same,
(3) a pharmaceutical composition
The present invention relates to novel substituted vinylcarboxylic acid derivatives which possess the action to inhibit specifically the thromboxane A.sub.2 (TXA.sub.2) synthetase.
TXA.sub.2 is a metabolite of arachidonic acid and has the platelet aggregating action. Therefore, it has been known
FIELD OF THE INVENTION
This invention relates to compounds that inhibit the secretion of apolipoprotein B, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia,
FIELD OF THE INVENTION
This invention relates to compounds that inhibit the secretion of apolipoprotein B, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia,
TECHNICAL FIELD
The present invention relates to carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient. More specifically, the present invention relates to (1) carboxylic acid derivatives represented by formula (I)
##STR00002## prodrugs thereof,
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to novel phthalazone derivatives and more particularly to compounds of the formula ##STR2## wherein R.sup.4 represents a carbamoyl (--CONH.sub.2) group, a dialkylaminoalkylcarbamoyl group, a hydroxyalkylcarbamoyl